September 2016 - Cancer Currents Blog
- Studies Highlight Potential of Targeting HIF-2 in Kidney Cancer
Two new studies suggest that a new class of drugs can effectively target a molecular driver of the most common type of kidney cancer.
- Many Cancer Caregivers Report Feeling Unprepared for Caregiving Challenges
Many family members who care for loved ones with cancer do not feel adequately prepared for the caregiving tasks they assume and need help to make informed decisions about end-of-life care, according to a new study.
- Chromosomal Instability Score May Predict Response to Cancer Treatment
A new study suggests that a chromosomal instability score may help guide treatment choices for patients with cancer.
- Forging Collaborations to Spur Global Progress against Cancer
NCI and NIH announce efforts to establish international collaborations that can accelerate progress in reducing the global cancer burden.
- Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer Moonshot
NCI’s new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.
- The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.
Dr. Greg Armstrong of the Childhood Cancer Survivor Study discusses this long-running study and its future.
- Pancreatic Cancer Cells May Obtain Nutrients from Neighboring Cells
Pancreatic cancer cells instruct healthy cells around them to provide nutrients they need to survive and grow, a new study suggests.
- Blue Ribbon Panel Report: The Power of the Cancer Community Coming Together
NCI Acting Director Dr. Douglas R. Lowy, M.D., thanks the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.
- Approach May Allow for Stem Cell Transplant without Radiation, Chemotherapy
In a recent study, researchers showed that a new approach may provide a safer way to perform stem cell transplants for treating cancer and other diseases.
- Engineered Stem Cells Help Identify Potential New Treatment for Medulloblastoma
Stem cells engineered to mimic medulloblastoma development may help researchers identify potential new treatments, according to a new study.